Joel S. Marcus, JD, CPA

Joel S. Marcus is Executive Chairman and Founder of Alexandria Real Estate Equities, Inc. (NYSE: ARE), a REIT that pioneered life science real estate and transformed it from a specialty niche to a mainstream asset class. Alexandria is the preeminent, largest, and longest-tenured owner, operator, and developer uniquely focused on collaborative mega campuses in AAA life science innovation clusters.

Since co-founding Alexandria in 1994 as a garage startup with $19 million in Series A capital, Mr. Marcus has led its remarkable growth into an S&P 500 company that has become the leading REIT focused on the life science industry, with a total market capitalization of $33.1 billion and an operating asset base of 42 million square feet as of September 30, 2024. Alexandria, which celebrated its 25th anniversary on the NYSE in May 2022, has a total stockholder return of 1,459% from its IPO in May 1997 through September 30, 2024.

In 1996, Mr. Marcus founded Alexandria Venture Investments, the company’s strategic venture capital platform, and he continues to lead its investments. With approximately $1.5 billion under management as of September 30, 2024, Alexandria Venture Investments actively invests in disruptive life science companies. He introduced Alexandria’s thought leadership vertical in 2011 when he co-founded the renowned Alexandria Summit®.

He also leads Alexandria’s corporate responsibility initiatives, which aim to address some of the nation’s most urgent challenges, including mental health and addiction. To reverse the trajectory of the opioid epidemic, Alexandria partnered with Verily, an Alphabet company, to pioneer OneFifteen, an evidence-based full continuum of care model to treat addiction.

Prior to co-founding Alexandria, Mr. Marcus had an extensive legal career specializing in corporate finance and capital markets, venture capital, and mergers and acquisitions. During that time, he acquired expertise in the biopharmaceutical industry and was one of the principal architects of Kirin-Amgen, Inc., the trailblazing joint venture established in 1984. Mr. Marcus serves on the boards of Applied Therapeutics, Inc. (NASDAQ: APLT) and Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) as well as several private biotechnology companies and non-profits, including the 9/11 Memorial & Museum, Emily Krzyzewski Center, National Medal of Honor Museum, Navy SEAL Foundation, Office of Strategic Services Society, and TOPGUN Association. He received his BA and JD from UCLA.